Closer to FDA approval in USA for Cannabis Children Epilepsy drug, page-2

This is just another small step that will add up for MXC by the end of 2018. Future FDA approval for CannEpil in the USA, more EU countries loosening restraints on MM, Full GMP certification, Malta and Australian developments. The more time that goes by it seems MXC just keeps ticking boxes - or boxes are ticked for them.
Great reporting Boston44. Keep them coming.
Question: it appears from your posts that MM is sprinting in North America. Is the momentum there as rampant as we are led to believe? I suspect that Australia which follows the US lead in most things will increase MM momentum here if the US moves far enough.